Search
Now showing items 1-1 of 1
Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma
Viardot, Andreas et al. (2016)
Wissenschaftlicher Artikel
Now showing items 1-1 of 1